The overall difference within the assessment of all three parameters (HGF, OPN, SYN) in MGUS and individual phases of MM course (i.e., at the time of diagnosis, in relapse/progression and in remission of the disease) was statistically significant (P < 0.0001). The gene discussed is SPP1; the disease is Miyoshi myopathy.